DTL
CADX

Dynamic Technology Lab’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Dynamic Technology Lab’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-14,283
Closed -$129K – 884
2013
Q4 		$129K Buy
+14,283
New +$103K 0.09% 449

Other funds holding CADX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dynamic Technology Lab's CADX Position: Q1 2014 in Review

Dynamic Technology Lab sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 14,283 shares — an estimated $129K sold.

Dynamic Technology Lab first reported a position in CADX in Q4 2013 and held it in 1 quarter. The position peaked at $129K in Q4 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

  • Dynamic Technology Lab reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
  • Dynamic Technology Lab sold 14,283 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $129K.
  • Dynamic Technology Lab first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q4 2013 and held it in 1 quarter.
  • Dynamic Technology Lab's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $129K in Q4 2013.
  • 3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on Dynamic Technology Lab's 13F filing for Q1 2014, filed 18 Aug 2014.